NEW YORK–(BUSINESS WIRE)–SnowPlus, a leading e-cigarette brand, is launching a new product line called the “Smokeless Edition” that removes all smoke from the vaping process. Its vapor-less feature allows no disturbance to the users’ surrounding, creating a game-changing innovation and new chapter for the e-cigarette market—the era of disturbance-free smoking. This new edition will be available globally on the official website starting in late August, 2019.
SnowPlus, Pioneer of the Industry
With the launch of new products like the “Smokeless Edition”, SnowPlus continues to innovate within the industry. Initially developed for atomization treatment, this piece of technology together with SnowPlus’ revolutionary e-liquid ratio manages to retain an authentic vaping experience while leaving no visible smoke exhaled.
Continuous Innovation to Lead the Global Market
SnowPlus attributes its success to its priority on R&D and quality control. The newly launched Smokeless Edition adopts the most advanced TrueFeel honeycomb ceramic atomization technology and Aeroflow air intake technology.
Derek Li, Co-Founder of SnowPlus, stated “We are expanding our product portfolio through continuous technological innovation. By the end of 2019, we expect to be one of the largest market leaders in the global e-cigarette market.”
SnowPlus strictly follows and abides by guidelines and regulations, including China’s QB/T 1506-2012 tobacco flavoring standard and U.S. FDA’s with 21 CFR 175.300 E regulations. The extensive list of safety certifications includes: CE and RoHS safety certificate from EU and PMA by FDA.
Founded in April 2019, SnowPlus is dedicated to providing safe alternatives to traditional cigarettes by bringing change to current health challenges around the globe and empowering adult smokers to lead more healthy lifestyles. Furthermore, SnowPlus launched the “Angel Protection Campaign” that aims to systematically prevent youth from accessing and using e-cigarettes. SnowPlus products have passed a number of third-party safety certifications and comply with the highest medical safety standards of the FDA and the European Union. To date, SnowPlus has received $40 million in Series A financing which is among the largest funding for any startup in the e-cigarette industry.
To learn more about SnowPlus, please go to snowplustech.com.